ReviewMolecules (Basel, Switzerland)2024
All-Visible-Light-Activated Diarylethene Photoswitches.
Review in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Bistable Switching of π-Conjugation in a Dithienylethene-Bridged Luminescent Trityl Diradicaloid.Angewandte Chemie (International ed. in English) · 2026Article
- Toward Higher Fatigue Resistance of Photochromic Polymer Layers Containing Novel Diarylethenes.ACS omega · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Photochromic compounds have attracted much attention for their potential applications in photo-actuators, optoelectronic devices and optical recording techniques. This interest is driven by their key photochemical and photophysical properties, which can be reversibly modulated by light irradiation. Among them, diarylethene compounds have garnered extensive investigation due to their excellent thermal stability of both open- and closed-form isomers, robust fatigue resistance, high photocyclization quantum yield and good photochromic performance in both solution and solid phases. However, a notable limitation in expanding the utility of diarylethene compounds is the necessity for ultraviolet light to induce their photochromism. This requirement poses challenges, as ultraviolet light can be detrimental to biological tissues, and its penetration is often restricted in various media. This review provides an overview of design strategies employed in the development of visible-light-responsive diarylethene compounds. These design strategies serve as a guideline for molecular design, with the potential to significantly broaden the applications of all-visible-light-activated diarylethene compounds in the realms of materials science and biomedical science.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.